Are current methods of measurement of erythropoietin (EPO) in human plasma or serum adequate for the diagnosis of polycythaemia vera and the assessment of EPO deficiency?

Author： Lindstedt G   Lundberg P-A  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.58, Iss.6, 1998-10, pp. : 441-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Red Cell Mass, Spleen Size and Plasma Erythropoietin in Polycythaemia vera and Apparent Polycythaemia

By  

Acta Haematologica, Vol. 108, Iss. 1, 2002-07 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin (rHuEPO) on Tumor Control in Patients with Cancer-Induced Anemia

By  

Oncology Research and Treatment, Vol. 28, Iss. 4, 2005-10 ,pp. : 216-221

Karger

Access to resources Recommend Favorite

Elevated Levels of Serum Vascular Endothelial Growth Factor in Patients with Polycythaemia vera

By  

Acta Haematologica, Vol. 110, Iss. 1, 2003-09 ,pp. : 16-19

Karger

Access to resources Recommend Favorite

Prevention of Anemia in Patients with Solid Tumors Receiving Platinum-Based Chemotherapy by Recombinant Human Erythropoietin (rHuEpo): A Prospective, Open Label, Randomized Trial by the Hellenic Cooperative Oncology Group

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 102-110

Karger

Access to resources Recommend Favorite

Assignment of erythropoietin (EPO) to blind subterranean mole rat chromosome 1q by in situ hybridization

By  

Cytogenetic and Genome Research, Vol. 108, Iss. 4, 2004-12 ,pp. : 362D-

Karger

Access to resources Recommend Favorite